Greenlight Capital Re Reports Q1 2026 Earnings Highlights
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 6 hours ago
0mins
Should l Buy GLRE?
Source: seekingalpha
- Net Income Growth: In Q1 2026, Greenlight Capital Re reported a net income of $35.8 million, driving a 4.7% increase in fully diluted book value per share, reflecting the company's strong capabilities in investment performance and underwriting profit.
- Underwriting Profit Analysis: The company achieved an underwriting profit of $6.2 million in the first quarter, with a combined ratio of 96.0%, despite a $5 million provision linked to the Middle East conflict, demonstrating robust performance in a challenging market.
- Innovation Segment Growth: The Innovations segment saw gross written premiums increase by 73% year-over-year to $47.6 million, indicating strong momentum from organic growth in the existing client portfolio and new business opportunities, which are expected to continue driving future revenue growth.
- Share Repurchase Plan: Year-to-date, the company has returned $14.5 million of capital to shareholders through its Board-approved share repurchase plan, and with a new authorization effective May 15, 2026, plans to repurchase an additional $40 million in stock, further enhancing shareholder value.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy GLRE?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on GLRE
About GLRE
Greenlight Capital Re, Ltd provides multiline property and casualty insurance and reinsurance through its licensed and regulated reinsurance entities in the Cayman Islands and Ireland, and its Lloyd’s platform, Greenlight Innovation Syndicate 3456. The Company’s segments include Open Market and Innovations. In the Open Market segment, the Company underwrites reinsurance business, sourced through the brokerage distribution channels and Lloyd’s. The Company writes treaty reinsurance on a proportional and non-proportional basis. Its lines of business include casualty, financial, health, multiline, property and specialty. In the Innovations segment, the Company provides reinsurance capacity to startup companies and managing general agents (MGAs) based globally, sourced mainly through direct placements with its strategic partners. This segment also includes business written by Syndicate 3456. Its lines of business include casualty, financial, health, multiline and specialty.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Premium Revenue Decline: In Q1 2026, Greenlight Capital reported an 8% decrease in gross premiums written to $227.9 million, reflecting increased market competition and customer attrition, which could impact future revenue growth.
- Underwriting Income Improvement: The net underwriting income of $6.2 million marks a significant turnaround from a $7.8 million loss in Q1 2025, indicating effective adjustments in risk management and underwriting strategies that enhance financial stability.
- Stable Investment Income: Total investment income stood at $40.4 million, a slight decrease of 0.2%, suggesting that the company has maintained stability in its investment portfolio management despite potential market volatility affecting short-term returns.
- Share Repurchase Program: The company repurchased $5 million of ordinary shares at an average cost of $16.70 per share during the quarter, demonstrating management's confidence in the company's long-term value while also helping to boost earnings per share.
See More
- Net Income Growth: In Q1 2026, Greenlight Capital Re reported a net income of $35.8 million, driving a 4.7% increase in fully diluted book value per share, reflecting the company's strong capabilities in investment performance and underwriting profit.
- Underwriting Profit Analysis: The company achieved an underwriting profit of $6.2 million in the first quarter, with a combined ratio of 96.0%, despite a $5 million provision linked to the Middle East conflict, demonstrating robust performance in a challenging market.
- Innovation Segment Growth: The Innovations segment saw gross written premiums increase by 73% year-over-year to $47.6 million, indicating strong momentum from organic growth in the existing client portfolio and new business opportunities, which are expected to continue driving future revenue growth.
- Share Repurchase Plan: Year-to-date, the company has returned $14.5 million of capital to shareholders through its Board-approved share repurchase plan, and with a new authorization effective May 15, 2026, plans to repurchase an additional $40 million in stock, further enhancing shareholder value.
See More

Greenlight Capital's Financial Agreement: Greenlight Capital has entered into a Master Letter of Credit Agreement with CIBC Bank USA, effective April 1, 2026.
Regulatory Filing: The agreement has been filed with the SEC, indicating compliance with regulatory requirements.
See More
- Strong Underwriting Profit: Greenlight Capital Re reported a net underwriting profit of $13 million in Q4 2025, with a combined ratio of 92.1%, which is 20 points better than the same period last year, demonstrating the company's ability to maintain profitability in a competitive market and boosting investor confidence.
- Robust Investment Returns: The company achieved net investment income of $44.8 million for the quarter, with $36.2 million stemming from Solasglas, reflecting successful portfolio management that supports overall financial performance and future growth potential.
- Continued Business Expansion: Greenlight grew its FAL book by approximately 21%, and despite an 11% rate decline in the specialty market, it leveraged an A.M. Best rating upgrade and strong partner relationships to achieve solid business expansion, enhancing its competitive position.
- Optimistic Outlook: Management expressed optimism for 2026, expecting the expense ratio in the Innovation segment to normalize over the next 18 to 24 months, indicating a focus on risk management and financial stability while expanding operations.
See More








